Emerging Company Profile

VCs led by HBM, Samsara back single-asset Mitsubishi Tanabe spinout Mineralys with $40M for hypertension program

Emerging Company Profile: Philadelphia biotech readying Phase II trial of compound it believes is differentiated by selectivity

Philadelphia biotech readying Phase II trial of compound it believes is differentiated by selectivity.

A VC syndicate led by HBM and Samsara will supply